NexgenRx Inc.
NXG.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 109.40K | 23.30K | 341.90K | -284.90K | -97.50K |
| Total Depreciation and Amortization | 227.10K | 235.50K | 236.50K | 234.20K | 240.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.70K | -8.20K | -7.10K | 72.50K | -5.30K |
| Change in Net Operating Assets | -229.80K | 470.10K | -961.80K | 270.20K | 391.10K |
| Cash from Operations | 97.10K | 720.70K | -390.50K | 292.10K | 528.40K |
| Capital Expenditure | -5.60K | -22.50K | -13.70K | -8.70K | -39.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -43.70K | -93.60K | -31.20K | 0.00 | -- |
| Cash from Investing | -49.30K | -116.10K | -44.90K | -8.70K | -39.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -26.50K | -24.10K | -20.70K | -27.30K | -17.30K |
| Issuance of Common Stock | 62.50K | -- | 125.00K | 0.00 | 62.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -24.20K | -283.30K | -24.50K | -307.70K | -24.60K |
| Other Financing Activities | -33.00K | 33.00K | -- | -- | -- |
| Cash from Financing | -22.00K | -276.80K | 52.90K | -327.80K | 9.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 25.70K | 327.80K | -382.50K | -44.50K | 497.70K |
